Skip to main content
Retour
Watch Compare

TherapeuticsMD, Inc.

Qualité des données : 67%
TXMD
NASDAQ Manufacturing Chemicals
2,07 €
▲ 0,02 € (0,98%)
Cap. Boursière: 23,50 M
Prix
2,03 €
Cap. Boursière
23,50 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-2,08%
Au-dessus de la moyenne du secteur (-54,01%)
ROIC-10,27%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio2,93
Interest Coverage-548,75

Valorisation

PE (TTM|NTM)
-41,29 | 5,91
En dessous de la moyenne du secteur (-1,49)
P/B Ratio0,86
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -41,3 -1,5
P/B 0,9 1,6
ROE % -2,1 -54,0
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q22023 -0,07 € -0,24 € -242,9%
Q12023 0,06 € -0,24 € -500,0%
Q42022 -1,11 € 8,23 € +841,4%
Q32022 -2,04 € -3,13 € -53,4%

ETFs Holding This Stock

BRSIX BRSIX
0,03% weight
EMAAX EMAAX
0,00% weight
EMACX EMACX
0,00% weight
EAAAX EAAAX
0,00% weight
EMAYX EMAYX
0,00% weight
GADVX GADVX
0,00% weight
GABCX GABCX
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -569 000,0
ROE -2,08% ROA -1,47%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC -10,27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,93
Interest Coverage -548,75 Asset Turnover N/A
Working Capital 9,56 M Tangible Book Value 23,53 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -41,29 Forward P/E 5,91
P/B Ratio 0,86 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield 16,92%
FCF Yield N/A
Market Cap 23,50 M Enterprise Value 23,50 M
Per Share
EPS (Diluted TTM) -0,05 Revenue / Share N/A
FCF / Share N/A OCF / Share N/A
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion N/A
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — 1,76 M 1,30 M 69,96 M 86,95 M
Net Income -569 000,0 -2,18 M -10,28 M 112,00 M -172,42 M
EPS (Diluted) -0,05 -0,19 -0,98 11,96 —
Gross Profit — — 1,30 M 68,57 M 68,11 M
Operating Income -4,39 M -4,76 M -8,52 M 1,19 M -139,77 M
EBITDA — — — — —
R&D Expenses — — — — 7,09 M
SG&A Expenses — 4,74 M — — —
D&A 384 000,0 509 000,0 922 000,0 1,19 M 4,09 M
Interest Expense 8 000,0 9 500,0 300 000,0 36,07 M 32,92 M
Income Tax -31 000,0 -31 000,0 -43 000,0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 37,66 M 38,82 M 43,31 M 90,46 M 169,47 M
Total Liabilities 10,78 M 11,45 M 14,02 M 55,32 M 263,09 M
Shareholders' Equity 26,88 M 27,37 M 29,29 M 35,14 M -93,62 M
Total Debt — — — 188,27 M 188,27 M
Cash & Equivalents — 5,06 M — — —
Current Assets 14,45 M 12,26 M 11,80 M 55,35 M 119,47 M
Current Liabilities 4,79 M 5,17 M 6,85 M 46,84 M 252,89 M